Differentiation of dermal papilla cells into a myogenic lineage for the treatment of duchenne muscular dystrophy

被引：0
|
作者：
Rashidi, M. [1 ]
Rufaut, N. [2 ]
Jones, L. [3 ]
Partridge, T. [4 ]
Sinclair, R. [3 ]
机构：
[1] George Washington Univ, Mclean, VA USA
[2] Univ Melbourne, Dunedin, New Zealand
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] George Washington Univ, Washington, DC USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2017年 / 137卷 / 10期
关键词：
D O I：
10.1016/j.jid.2017.07.083
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
LB1000
引用
收藏
页码：B12 / B12
页数：1
相关论文
共 50 条
  • [41] Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy
    Dort, Junio
    Orfi, Zakaria
    Fabre, Paul
    Molina, Thomas
    Conte, Talita C.
    Greffard, Karine
    Pellerito, Ornella
    Bilodeau, Jean-Francois
    Dumont, Nicolas A.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [42] Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells
    Skuk, D
    Roy, B
    Goulet, M
    Chapdelaine, P
    Bouchard, JP
    Roy, R
    Dugré, FJ
    Lachance, JG
    Deschênes, L
    Senay, H
    Sylvain, M
    Tremblay, JP
    MOLECULAR THERAPY, 2004, 9 (03) : 475 - 482
  • [43] Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy
    Shieh, Perry B.
    NEUROTHERAPEUTICS, 2018, 15 (04) : 840 - 848
  • [44] Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy
    Junio Dort
    Zakaria Orfi
    Paul Fabre
    Thomas Molina
    Talita C. Conte
    Karine Greffard
    Ornella Pellerito
    Jean-François Bilodeau
    Nicolas A. Dumont
    Nature Communications, 12
  • [45] Treatment of Duchenne muscular dystrophy at the mRNA level
    Matsuo, M
    Takeshima, Y
    FRONTIERS IN HUMAN GENETICS: DISEASES AND TECHNOLOGIES, 2001, : 347 - 356
  • [46] Colonic distension treatment in Duchenne muscular dystrophy
    Fiorentino, Giuseppe
    Esquinas, Antonio M.
    NEUROMUSCULAR DISORDERS, 2019, 29 (02) : 157 - 158
  • [47] Pharmacological prospects in the treatment of Duchenne muscular dystrophy
    Ruegg, Urs T.
    CURRENT OPINION IN NEUROLOGY, 2013, 26 (05) : 577 - 584
  • [48] Development of PPMO for the Treatment of Duchenne Muscular Dystrophy
    Passini, Marco A.
    Gan, Li
    Wood, Jenna A.
    Yao, Monica
    Estrella, Nelsa L.
    Treleaven, Chris M.
    Wentworth, Bruce M.
    Charleston, Jay S.
    Rutkowski, Joseph V.
    Hanson, Gunnar J.
    NEUROLOGY, 2018, 90
  • [49] Duchenne muscular dystrophy: diagnosis and perspective of treatment
    Angelini, Corrado
    JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS, 2024, 8 (02) : 244 - 248
  • [50] Eteplirsen for the Treatment of Duchenne Muscular Dystrophy (DMD)
    Charleston, J. S.
    Schnell, F. J.
    Dworzak, J.
    Donoghue, C.
    Lynch, J.
    Lewis, S.
    Chen, L.
    Rodino-Klapac, L. R.
    Sahenk, Z.
    Voss, J.
    DeAlwis, U.
    Frank, D. E.
    Eliopoulos, H.
    Mendell, J. R.
    NEUROLOGY, 2017, 88
12345